Publications by Dr Nicola Sunter - ePrints

Browsing publications by Dr Nicola Sunter.

Newcastle Authors	Title	Year
Dr Wei-yu Lin Dr Sarah Fordham Dr Nicola Sunter Dr Claire Elstob Dr Yaobo Xu et al.	Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia (Nature Communications, (2021), 12, 1, (6233), 10.1038/s41467-021-26551-x)	2022
Dr Wei-Yu Lin Dr Sarah Fordham Dr Nicola Sunter Dr Claire Elstob Dr Thahira Rahman et al.	Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemia	2021
Dr Wei-Yu Lin Dr Sarah Fordham Dr Nicola Sunter Dr Claire Elstob Dr Yaobo Xu et al.	Genome-wide association study identifies susceptibility loci for acute myeloid leukemia	2021
Dr Nicola Sunter Professor Graham Jackson Professor James Allan	Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology	2019
Dr Nicola Sunter Dr Andrew Hall Dr Tryfonia Mainou-Fowler Professor Graham Jackson Dr Helen Marr et al.	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia	2017
Dr Nicola Sunter Professor Graham Jackson Dr Thahira Rahman Professor James Allan	Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci	2017
Dr David Jamieson Dr Nicola Sunter Sara Muro Dr Nicola Cresti Julieann Sludden et al.	Pharmacogenetic association of MBL2 and CD95 polymorphisms with grade 3 infection following adjuvant therapy for breast cancer with doxorubicin and cyclophosphamide	2017
Dr Mark Wade Dr Nicola Sunter Dr Sarah Fordham Anna Long Dino Mašić et al.	c-MYC is a radiosensitive locus in human breast cells	2015
Dr Nicola Sunter Dr Helen Marr Dr Andrew Hall Dr Tryfonia Mainou-Fowler Professor Graham Jackson et al.	Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk	2015
Dr Nicola Sunter Dr Andrew Hall Dr Tryfonia Mainou-Fowler Professor Graham Jackson Professor James Allan et al.	A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia	2014
Dr Rachel Crossland Dr Kim Pearce Dr Nicola Sunter Dr Tryfonia Mainou-Fowler	MicroRNAs in B-cell chronic lymphocytic leukaemia (B-CLL): mature microRNAs of the miR-17-92 cluster predict for treatment free survival (TFS) in patients with B-CLL	2011
Dr Nicola Sunter Professor Graham Jackson Dr Simon Bomken Professor James Allan	A Functional Polymorphism In the CD95 Cell Death Receptor Associated with Prognosis In Acute Promyelocytic Leukemia	2010
Professor Graham Jackson Dr Nicola Sunter Dr Andrew Hall Professor Julie Irving Professor James Allan et al.	A polymorphism in the 3' UTR of IRF4 linked to susceptibility and pathogenesis in chronic lymphocytic leukaemia and Hodgkin lymphoma has limited impact in multiple myeloma	2010
Dr Nicola Sunter Dr Andrew Hall Dr Tryfonia Mainou-Fowler Professor Graham Jackson Professor James Allan et al.	Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk	2010
Dr Nicola Sunter Dr Ian Cowell Dr Elaine Willmore Gary Watters Professor Caroline Austin et al.	Role of Topoisomerase IIbeta in DNA Damage Response following IR and Etoposide	2010
Professor James Allan Dr Nicola Sunter Dr Andrew Hall Dr Christopher Bacon Jonathan Pointon et al.	Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemia	2010
Professor James Allan Dr Nicola Sunter Dr Andrew Hall Dr Tryfonia Mainou-Fowler Professor Graham Jackson et al.	A Common Genetic Variant in the 3'UTR of IRF4/MUM1 Associates with Risk of Disease and Poor Prognosis in Chronic Lymphocytic Leukaemia	2008
Dr Nicola Sunter Dr Andrew Hall Dr Tryfonia Mainou-Fowler Professor Graham Jackson Professor James Allan et al.	A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia	2008
Dr Ian Cowell Dr Nicola Sunter Professor Caroline Austin Professor barbara Durkacz Dr Michael Tilby et al.	γH2AX foci form preferentially in euchromatin after ionising-radiation	2007
Dr Elaine Willmore Dr Nicola Sunter Dr Michael Tilby Professor Graham Jackson Professor Caroline Austin et al.	A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia	2004